Clinical characteristics of XP11.2 translocation/TFE3 gene fusion renal cell carcinoma: a systematic review and meta-analysis of observational studies

被引:37
作者
Cheng, Xiangming [1 ]
Gan, Weidong [1 ]
Zhang, Gutian [1 ]
Li, Xiaogong [1 ]
Guo, Hongqian [1 ]
机构
[1] Nanjing Univ, Sch Med, Affiliated Hosp, Dept Urol,Nanjing Drum Tower Hosp, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Age groups; Carcinoma; Gender identity; Renal cell; Xp11.2; translocation; APART FISH ASSAY; AGGRESSIVE COURSE; ADULTS; CHILDREN; EXPERIENCE; DIAGNOSIS; FEATURES;
D O I
10.1186/s12894-016-0154-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Renal cell carcinoma (RCC) associated with Xp11.2 translocation/TFE3 gene fusion (Xp11.2 RCC) is a rare subtype of RCC which is firstly described as a distinct entity in 2004 so that clinical characteristics of Xp11.2 RCC in different gender and age are unknown. The purpose of systematic review and meta-analysis is to provide a comprehensive assessment on them. Methods: MEDLINE, EMBASE and Cochrane databases were searched for studies which evaluate the clinical characteristics of Xp11.2 RCC. The literature published between July 2004 and May 2014 was searched. Results: A total of 15 studies with 147 participants were included. The meta-analysis demonstrated that number of patients of all age in female was higher than in male with pooled OR of 3.93(95 % CI = 1.66-9.34). However, incidence of distant metastases (OR = 0.34, 95 % CI = 0.12-1.57) and lymphatic metastases (OR = 0.51, 95 % CI = 0.14-1.91), tumor stage (OR = 0.85, 95 % CI = 0.34-2.15) and overall survival (OS) (OR = 0.46, 95 % CI = 0.05-4.34) between male and female were comparable. Incidence in female was higher than in male with pooled OR of 5.13(95 % CI = 1.67-15.72) in adults, while in children no gender-related predominance (OR = 1.19, 95 % CI = 0.38-3.72) was observed. In addition, incidence of distant metastases (OR = 1.00, 95 % CI = 0.13-7.84) and lymphatic metastases (OR = 1.00, 95 % CI = 0.07-13.67) and tumor stage (OR = 1.94, 95 % CI = 0.20-19.03) between children and adults were comparable. Survival curves presented comparable outcomes between male and female (P = 0.707) as well as between children and adults (P = 0.383). Conclusions: Female patients with Xp11.2 RCC in adults exhibit a high incidence compared to male, but not in children. Comparable clinical characteristics including incidence of distant and lymphatic metastases, tumor stage and prognosis is presented between male and female as well as between children and adults.
引用
收藏
页数:9
相关论文
共 33 条
[1]  
Ahluwalia P, 2013, CASE REPORTS UROLOGY, V2013, P1
[2]   Pediatric renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and clinicopathologic associations [J].
Altinok, G ;
Kattar, MM ;
Mohamed, A ;
Poulik, J ;
Grignon, D ;
Rabah, R .
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2005, 8 (02) :168-180
[3]   Xp11 translocation renal cell carcinoma in adults: Expanded clinical, pathologic, and genetic spectrum [J].
Argani, Pedram ;
Olgac, Semra ;
Tickoo, Satish K. ;
Goldfischer, Michael ;
Moch, Holger ;
Chan, David Y. ;
Eble, John N. ;
Bonsib, Stephen M. ;
Jimeno, Mireya ;
Lloreta, Josep ;
Billis, Athanase ;
Hicks, Jessica ;
De Marzo, Angelo M. ;
Reuter, Victor E. ;
Ladanyi, Marc .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (08) :1149-1160
[4]  
Armah HB, 2010, ARCH PATHOL LAB MED, V134, P124, DOI 10.1043/2008-0391-RSR.1
[5]   Morphologic and molecular characterization of renal cell carcinoma in children and young adults [J].
Bruder, E ;
Passera, O ;
Harms, D ;
Leuschner, I ;
Ladanyi, M ;
Argani, P ;
Eble, JN ;
Struckmann, K ;
Schraml, P ;
Moch, H .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (09) :1117-1132
[6]   Vascular Endothelial Growth Factor-Targeted Therapy for the Treatment of Adult Metastatic Xp11.2 Translocation Renal Cell Carcinoma [J].
Choueiri, Toni K. ;
Lim, Zita Dubauskas ;
Hirsch, Michelle S. ;
Tamboli, Pheroze ;
Jonasch, Eric ;
McDermott, David F. ;
Dal Cin, Paola ;
Corn, Paul ;
Vaishampayan, Ulka ;
Heng, Daniel Y. C. ;
Tannir, Nizar M. .
CANCER, 2010, 116 (22) :5219-5225
[7]   Diagnosis of Xp11 translocation renal cell carcinomas in adult patients under 50 years: Interest and pitfalls of automated immunohistochemical detection of TFE3 protein [J].
Gaillot-Durand, L. ;
Chevallier, M. ;
Colombel, M. ;
Couturier, J. ;
Pierron, G. ;
Scoazec, J. Y. ;
Mege-Lechevallier, F. .
PATHOLOGY RESEARCH AND PRACTICE, 2013, 209 (02) :83-89
[8]  
Green WM, 2013, AM J SURG PATHOL, V37, P1150, DOI 10.1097/PAS.0b013e31828a69ae
[9]   Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases [J].
Hodge, Jennelle C. ;
Pearce, Kathryn E. ;
Wang, Xiaoke ;
Wiktor, Anne E. ;
Oliveira, Andre M. ;
Greipp, Patricia T. .
MODERN PATHOLOGY, 2014, 27 (01) :113-127
[10]   XP11.2 Translocation renal cell carcinoma: Clinical experience of Taipei Veterans General Hospital [J].
Hung, Chia-Chen ;
Pan, Chin-Chen ;
Lin, Chih-Chieh ;
Lin, Alex T. L. ;
Chen, Kuang-Kuo ;
Chang, Yen-Hwa .
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2011, 74 (11) :500-504